| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 711885 | Null | 0.0145418727063286 | 0.32661519 |
| NSC 736443 | 7-fluoro-2-(2-furoyl)-3-trifluoromethylquioxaline 1,4-dioxide | 0.0145418727063286 | 0.72791514 |
| NSC 744023 | (11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.0145418727063286 | 0.28677126 |
| NSC 729998 | Null | 0.0170494763533717 | 0.16600324 |
| NSC 293046 | Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide | 0.0176693828663437 | 0.49064405 |
| NSC 339638 | 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt | 0.0176693828663437 | 0.39527542 |
| NSC 348121 | 4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- | 0.0176693828663437 | 0.4221597 |
| NSC 352741 | Null | 0.0176693828663438 | 0.52477254 |
| NSC 355063 | Granatomycin A | 0.0176693828663438 | 0.23271547 |
| NSC 618262 | Null | 0.0176693828663438 | 0.728845 |